Regulation of megakaryocyte phenotype in human erythroleukemia cells.
about
Cloning of the cDNA for human 12-lipoxygenaseHuman platelet glycoprotein V: characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteinsPhosphorylation of human pleckstrin on Ser-113 and Ser-117 by protein kinase CTescalcin is an essential factor in megakaryocytic differentiation associated with Ets family gene expressionDiagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 casesInduction of megakaryocytic differentiation in primary human erythroblasts: a physiological basis for leukemic lineage plasticity.A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cellsEukaryotic translation initiation factor 6 is a novel regulator of reactive oxygen species-dependent megakaryocyte maturationIdentification and Characterization of the Cytoplasmic Antiproteinase (CAP) in Human PlateletsSynergistic effect of hydrogen peroxide on polyploidization during the megakaryocytic differentiation of K562 leukemia cells by PMA.Properties of the demarcation membrane system in living rat megakaryocytes.A potential role for protein kinase C-epsilon in regulating megakaryocytic lineage commitment.Historical review: megakaryopoiesis and thrombopoiesisRole for MKL1 in megakaryocytic maturation.Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4.Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.PKCα negatively regulates in vitro proplatelet formation and in vivo platelet production in mice.Thrombopoietin from beginning to end.Thrombopoietin and platelet developmentThe human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets.AF10 plays a key role in the survival of uncommitted hematopoietic cells.Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy.The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1.Selective Exo-Enzymatic Labeling Detects Increased Cell Surface Sialoglycoprotein Expression upon Megakaryocytic DifferentiationMR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation.Increased expression of HIF2α during iron deficiency-associated megakaryocytic differentiation.Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content.Ganglioside GM3 is required for caffeic acid phenethyl ester-induced megakaryocytic differentiation of human chronic myelogenous leukemia K562 cells.IL-13 upregulates GPIIb expression in megakaryocytic cell lines via STAT6.Role of metallothionein in differentiation of leukemia cells.Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.K-252a-induced polyploidization and differentiation of a human megakaryocytic cell line, Meg-J: transient elevation and subsequent suppression of cyclin B1 and cdc2 expression in the process of polyploidization.Induction of polyploidization in the human erythroleukemia cell line (HEL) by protein kinase inhibitor (K252a) and the phorbol-ester TPA.Evaluation of effects of various drugs on platelet functions using phorbol 12-myristate 13-acetate-induced megakaryocytic human erythroid leukemia cells.AP-1/C-jun and C-myc Regulation During Megakaryocytic Differentiation of a Human Bi-potential Growth-factor-dependent Cell Line.Gene expression during phorbol ester-induced differentiation of cultured human megakaryoblastic cells.Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation.Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins.Transactivation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb.
P2860
Q24299952-33AE105B-4EB5-4E5C-AD22-F3BA30795E6BQ24310691-CE3174D5-E4C4-49FF-ACF6-7346B2B25857Q24336180-B8774F2D-E9E1-4E70-BD4D-7579A31C2B33Q24338289-9542B3EF-7E34-4193-82AB-A016D42F3798Q28143195-6E8FA89C-9211-485A-A8B3-9846B75CB094Q28362042-15C98C4A-7BAB-4A71-B527-BAF149636D7DQ28486933-26F25686-3C4E-40F6-8A35-C74FE03E953FQ28506261-300D944F-B179-46B6-87B1-10DA06C21C05Q29999528-8F78D02D-5640-435E-B690-8B1447D9BD68Q30432903-01FCEA5F-10F8-4F36-9309-0037D6963998Q30476424-233EABF1-A8BF-46E2-8383-AA453D9B0748Q31443813-3ADA80CC-97AA-458E-B369-C1A763D1C910Q33378422-B51EDA87-2548-46F9-90D2-D7997F582D12Q33382736-55578B48-21B5-407F-9CE6-3F518D797169Q33393133-82300FF8-5F05-4970-BBDC-7399BDC3542AQ33393742-5D0E5049-FA06-4B71-82B4-D5D49249810DQ33405817-F394C0B3-0850-4D49-98D6-2E9A830BBDE1Q33413170-87FEC9F3-C2E0-4145-A396-78B4F0C95CBAQ34182903-2A1D7BD1-AB7A-4F91-ADFD-A52E1EB9C0B9Q34470489-89865F12-5FEC-4B7A-A0B4-A33A6D6DA05EQ34532074-92B8D7C6-6016-423D-84D6-9144FC698E23Q35763773-9261FF2E-2C4B-4EDC-8CDC-A3E9A398A025Q36201496-CA0B4E97-9D1F-4C10-A60E-01D433914D49Q36302755-7F7C9BEF-6108-49A9-8985-2BB736340669Q36594681-256AF3D9-A90C-4E3B-BEEB-79A929AD7AD4Q36736547-9668E26C-4F8A-4802-B78E-BCD2781F11F8Q37105571-9F62696A-796C-4388-AA4F-C3F8EE9403ECQ37379580-37D884DC-52E1-4276-9FB5-D39277C1C190Q38984260-E7A80059-5889-46D0-AD1F-1D048E73F2E1Q39676834-047B09D1-956D-4EC8-894B-DD3956D97EA3Q39744601-E83FF225-B00E-4ED9-A089-24DEFC70EB89Q39809132-69C4E8AE-F0C5-4DCC-A386-9A034E96A685Q41012159-D8757ACC-A072-45B4-A4C9-BB3C7B55ECFFQ41117856-D892D836-0764-4AD6-9AFF-6DF0FFDC5D64Q41256836-623392E4-9606-487B-B97F-78243EDA6CF9Q41382571-4B995EFA-3D06-4D01-84CB-F5E4F2DA5CDDQ41468264-982E7439-69F1-48CC-B15D-1800CA4058F3Q41826479-2BA482D0-91F9-450E-9DDF-EDD16980FD5DQ42151281-DCB6AC16-AD0A-4657-B914-09DA110E126BQ48042630-57ED7429-854D-4AB5-8469-C4DB8C52FFFA
P2860
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@ast
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@en
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@nl
type
label
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@ast
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@en
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@nl
prefLabel
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@ast
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@en
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@nl
P2093
P2860
P356
P1476
Regulation of megakaryocyte phenotype in human erythroleukemia cells.
@en
P2093
C H Heffner
E V Prochownik
J L Williams
P2860
P304
P356
10.1172/JCI114538
P407
P577
1990-04-01T00:00:00Z